Intravenous iron does not effectively correct preoperative anaemia in cardiac surgery: a pilot randomized controlled trial.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 16 02 2018
revised: 12 06 2018
accepted: 15 06 2018
pubmed: 15 8 2018
medline: 14 8 2019
entrez: 15 8 2018
Statut: ppublish

Résumé

Preoperative anaemia is a strong predictor of blood transfusion requirements and must be assessed for appropriate optimization before elective surgery. Iron therapy is a transfusion-sparing approach effective for increasing haemoglobin concentrations. However, its role in elective cardiac surgery and the optimal route of administration remain unknown. This single-centre, non-blinded, randomized, controlled trial compared the effectiveness of intravenous ferric carboxymaltose therapy with oral iron for anaemic patients undergoing elective cardiac surgery. Fifty anaemic patients scheduled for elective cardiac surgery were randomized to receive either oral or intravenous iron therapy 3-8 weeks preoperatively. Changes in haemoglobin concentration were measured. Blood transfusion and postoperative outcome data were collected. Preoperative median increases in haemoglobin were 1.0 g/l (interquartile range -3.25 to 7.25 g/l) and 3.0 g/l (interquartile range -1.25 to 6.25 g/l) for patients receiving intravenous and oral iron, respectively (P = 0.42). The median first 12-h blood loss was significantly higher in the intravenous group (655 ml; interquartile range 162-1540 ml) compared to the oral group (313 ml; interquartile range 150-1750 ml; P < 0.007). Median increments in serum ferritin were superior for the intravenous group (median difference 313 µg/l; interquartile range 228-496) compared to the oral group (median difference 5.5 µg/l; interquartile range -1.4 to 19.4; P < 0.001). Increases in ferritin after intravenous iron administration were significantly greater than those after oral iron administration. There was no significant difference in haemoglobin increments between groups. Despite significantly higher intraoperative blood loss in the group receiving intravenous iron, blood transfusion requirements for both groups were not statistically different. ISRCTN22158788.

Identifiants

pubmed: 30107449
pii: 5068638
doi: 10.1093/icvts/ivy226
doi:

Substances chimiques

Hemoglobins 0
Iron E1UOL152H7

Banques de données

ISRCTN
['ISRCTN22158788']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Pagination

447-454

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Hari Padmanabhan (H)

Department of Gastroenterology, Royal Wolverhampton NHS Trust, Wolverhampton, UK.

Keith Siau (K)

Department of Gastroenterology, Royal Wolverhampton NHS Trust, Wolverhampton, UK.

Alan M Nevill (AM)

Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, UK.

Ian Morgan (I)

Department of Cardiothoracic Surgery, Heart & Lung Centre, Wolverhampton, UK.

James Cotton (J)

Department of Cardiology, Heart & Lung Centre, Wolverhampton, UK.

Alex Ng (A)

Department of Cardiothoracic Anaesthesiology, Heart & Lung Centre, Wolverhampton, UK.

Matthew J Brookes (MJ)

Department of Gastroenterology, Royal Wolverhampton NHS Trust, Wolverhampton, UK.

Heyman Luckraz (H)

Department of Cardiothoracic Surgery, Heart & Lung Centre, Wolverhampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH